Genotyping Assay Market Surges to USD 37.1 Billion by 2029: Thermo Fisher and Illumina at the Forefront | MarketsandMarkets™.
Comunicato Precedente
Comunicato Successivo
Browse in-depth TOC on "Genotyping Assay Market"
444 - Tables
59 - Figures
388 - Pages
The May 2024 edition of the genotyping assay market report introduces significant enhancements and updates to provide a comprehensive view of the market:
These enhancements in the May 2024 edition aim to deliver deeper insights and a more comprehensive understanding of the genotyping assay market, aiding stakeholders in strategic decision-making and market evaluation.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=249958595
Market Segmentation by Product & Service
The genotyping assay market is segmented into reagents and kits, instruments, genotyping assay services, and bioinformatics. In 2023, the reagents & kits segment held the largest market share. This dominance is driven by the accessibility of a wide range of reagents, increasing demand due to rising genotyping assay test volumes globally, and the relatively lower capital investment needed for adoption in pharmaceuticals and diagnostic centers.
Market Segmentation by Technology
The market is segmented into polymerase chain reaction (PCR), microarrays, capillary electrophoresis, sequencing, MALDI-TOF, and other technologies. PCR emerged as the largest segment in 2023, propelled by advancements like real-time PCR, reverse transcriptase PCR, and applications in personalized medicine, genetics, prenatal testing, and forensics. Technological enhancements in PCR instruments and reagents further bolstered its market growth.
Market Segmentation by Application
Segmented into pharmacogenomics, diagnostics & personalized medicine, agricultural biotechnology, animal genetics, and other applications, pharmacogenomics led the market in 2023. This segment's growth is fueled by increasing demand to study adverse drug reactions in clinical trials, reduce drug development costs, and advancements in personalized medicine and genetic research.
Market Segmentation by End User
The market includes biopharmaceutical & pharmaceutical companies, diagnostic laboratories, academic & research institutes, and other end users. Biopharmaceutical & pharmaceutical companies dominated in 2023, driven by rising demand for pharmacogenomics in drug discovery, FDA recommendations for genotyping assay studies, new product launches, and increased investments in pharmacogenomics research.
Regional Segmentation
The global market spans North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries. North America leads, supported by widespread adoption of advanced genotyping assay products, government funding for research, growing pharmacogenomics applications, investments in DNA-based testing, adoption of NGS, and presence of key market players.
These segments reflect the dynamic landscape of the genotyping assay market, highlighting key drivers and trends shaping its evolution across regions and industries.
Recent developments in the genotyping assay industry include:
For more information, inquire now! Inquire Now
Related Reports:
Next Generation Sequencing Market
Single cell Analysis Market
Molecular Diagnostics Market
Mass Spectrometry Market
Animal Genetics Market
Get access to the latest updates on Genotyping Assay Companies and Genotyping Assay Market Share
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original content:https://www.prnewswire.co.uk/news-releases/genotyping-assay-market-surges-to-usd-37-1-billion-by-2029-thermo-fisher-and-illumina-at-the-forefront--marketsandmarkets-302176670.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
